Evaluate CAPR stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in CAPR? | Glauxie AI

Q: What are the risks of investing in CAPR?

Capricor Therapeutics, Inc. (CAPR) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Linda MarbÃ¡n. Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of... Employees: 231.

Q: How much debt does CAPR have?

Review CAPR total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is CAPR a good long-term investment?

Evaluate CAPR as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in CAPR?

🦉

Capricor Therapeutics, Inc. (CAPR)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOLinda MarbÃ¡n

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy,...

Key Executives

Name	Title
Anthony J. Bergmann	Chief Financial Officer & Corporate Treasurer
Catherine Lee Kelleher	Consultant
Frank Isaac Litvack FACC	Executive Chairman of the Board
Karen G. Krasney	Executive Vice President, General Counsel & Secretary
Kristi A. H. Elliott	Chief Operating & Science Officer
Linda Marbán	Co-Founder, President, Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

CAPR Profile Financials

Is CAPR stock safe? How much debt does CAPR have? Is CAPR a good long-term investment?